Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NIMBLE System

Financiado

"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the...

"The NIMBLE System: A novel non-invasive and non-ionizing medical device for the continous monitoring of patients with implanted cardiovascular stents""" At NIMBLE Diagnostics we are developing a first-in-class microwave-based medical device for the non-invasive and non-ionizing monitoring of patients with implanted stents. Stents are one of the most implanted devices worldwide and... ver más

31/01/2026

NIMBLE DIAGNOSTICS...

3M€

Presupuesto del proyecto: 3M€

Líder del proyecto

NIMBLE DIAGNOSTICS Fabricación de equipos de radiación, electromédicos y electroterapéuticos sociedad limitada

TRL 8-9

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-01-15

HORIZON-EIC-2023-ACCELERATOROPEN-01: EIC Accelerator Open 2023 Scope:The EIC Accelerator Open has no predefined thematic priorities and is open to proposals in any...

I+D

Cerrada hace 2 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

NIMBLE DIAGNOSTICS

2.31M€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

NIMBLE WOMENTECHEU A novel non-invasive and non-ionizing medical device for mon... 75K€ Cerrado

TEC2013-49465-EXP DETECCION DE DEFECTOS ESTRUCTURALES POR DETERIORO DE STENTS... 92K€ Cerrado

BES-2010-032893 INSTRUMENTACION NO INVASIVA PARA MONITORIZAR Y EVALUAR TENDE... 43K€ Cerrado

PCIN-2013-068 CATETERES INTELIGENTES EN SISTEMAS AVANZADOS PARA INTERVENCI... 25K€ Cerrado

CPP2021-008562 CARE-ECGI - Terapia de resincronización cardiaca basada en i... 708K€ Cerrado

RTC-2016-5439-1 EneHeart (Sistema de medición de gasto cardiaco no invasivo) 330K€ Cerrado

Duración del proyecto: 24 meses Fecha Inicio: 2024-01-15
Fecha Fin: 2026-01-31

Líder del proyecto

NIMBLE DIAGNOSTICS Fabricación de equipos de radiación, electromédicos y electroterapéuticos sociedad limitada

TRL 8-9

Presupuesto del proyecto 3M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto At NIMBLE Diagnostics we are developing a first-in-class microwave-based medical device for the non-invasive and non-ionizing monitoring of patients with implanted stents. Stents are one of the most implanted devices worldwide and are used to re-open blocked arteries and restore the correct flow of blood or other fluids. They are especially useful to prevent heart attacks or to treat their lasting symptoms, but, after implantation, become blocked or damaged in 30% of cases. Symptoms only appear after a stent is already 90% dysfunctional, which increases the incidence of serious complications, including strokes, heart attacks or sudden death. Diagnosis of malfunctioning stents is still symptom-driven and is based on an invasive procedure called catheter angiography, involving anesthesia, X-ray exposure and 24h hospitalization recovery. This complex, costly and invasive procedure is not appropriate for ongoing monitoring, which is why the standard of care only reacts when patients already have potentially life-threatening symptoms. The NIMBLE System can read the electromagnetic signature of any stent non-invasively in less than 5 seconds and can be used to provide information on stent status and malfunction during regular clinical visits. Thus, NIMBLE enables early treatments to prevent negative outcomes and personalization of therapy, shifting from reactive to proactive care. Our technology is currently at TRL5/6, with an MVP that has shown excellent results in pre-clinical validations. We have also started the first-in-human testing in a pilot study of 30 patients that will finish early 2024. The EIC Accelerator program will allow us to bridge the biggest risk of our project by performing the regulatory clinical trial to obtain the CE mark, as well as support us to create and access a multi-billion blue ocean market opportunity. This will allow us to establish NIMBLE as a European leader in the future of implant diagnostics and aid millions of patients worldwide.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores